Home

Prominence of prophylaxis to prevent Venous Thromboembolism

To link to the entire object, paste this link in email, IM or document
To embed the entire object, paste this HTML in website To link to this page, paste this link in email, IM or document
To embed this page, paste this HTML in website

Prominence of prophylaxis to prevent Venous Thromboembolism

you wish to report:

Your comment:

Your Name:

...

Title	Prominence of prophylaxis to prevent Venous Thromboembolism
Subject	Venous Thrombosis; Thrombophlebitis, Prevention; Thromboembolism, Prevention; Pulmonary embolism, Prevention.
Description	Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is the prevalent hospital acquired cause of death based on research evidence. VTE affect 350,000 to 600,000 people yearly in the United States with death of 100,000 people a year (Baser, Supina, Sengupta, Wang & Kwong, 2010). Evidence-based research suggests that only 49% of patients are receiving prophylactic measures regardless of prophylactic guidelines. The consequences of VTE are mortality, morbidity, prolong duration of hospital stay, recurrent hospitalization, high Medicare cost, burden to health care, and affect the quality improvement of organization. The incidence of VTE and related issues can be prevented by proper use of mechanical and pharmacological measures alone or in combination with evidence-based guideline, which is effective and safe. The drawbacks of following the prophylactic guideline include knowledge deficit among health care providers on risk assessment tools,
Creator	Abraham, Sujitha.
Publisher	Grand Canyon University
Date	2014
Type	text
Format	PDF
Identifier	EBN_2014_Abraham_Su_1205
Source	2014_Abraham_Su_1205
Language	eng

Title	Prominence of prophylaxis to prevent Venous Thromboembolism
Subject	Venous Thrombosis; Thrombophlebitis, Prevention; Thromboembolism, Prevention; Pulmonary embolism, Prevention.
Description	Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is the prevalent hospital acquired cause of death based on research evidence. VTE affect 350,000 to 600,000 people yearly in the United States with death of 100,000 people a year (Baser, Supina, Sengupta, Wang & Kwong, 2010). Evidence-based research suggests that only 49% of patients are receiving prophylactic measures regardless of prophylactic guidelines. The consequences of VTE are mortality, morbidity, prolong duration of hospital stay, recurrent hospitalization, high Medicare cost, burden to health care, and affect the quality improvement of organization. The incidence of VTE and related issues can be prevented by proper use of mechanical and pharmacological measures alone or in combination with evidence-based guideline, which is effective and safe. The drawbacks of following the prophylactic guideline include knowledge deficit among health care providers on risk assessment tools, timely initiation of therapy, lack of motivation, noncompliance of patient and nurses, unavailability of resources, and lack of support from organization. A proposed plan is an implemented and evaluated outcome to increase awareness of prophylactic measures. Changed plan is supported and approved by stakeholders and disseminated to the nursing community. Researches showed that nurses have vital responsibility in inhibiting the incidence of VTE by early identification, proper risk assessment tool, patient and family education, timely initiation of appropriated treatment, advocating and collaborating with multidisciplinary team, and providing evidence-based care (Cawley, 2008). Different evidence-based approaches implemented on the new plan in the clinical setting are improving nurses and patient perception on treatment, knowledge, and compliance and assessing the barriers in present guideline. Methods used in the new plan are education session by audio-visual method, charts reviews by retrospective method, and conferences. In conclusion, the changed plan provided substantial improvement in VTE prevention, reduction in mortality, morbidity, high quality improvement, and cost effectiveness.
Creator	Abraham, Sujitha.
Publisher	Grand Canyon University
Date	2014
Type	text
Format	PDF
Identifier	EBN_2014_Abraham_Su_1205
Source	2014_Abraham_Su_1205.pdf
Language	eng

Prominence of prophylaxis to prevent Venous Thromboembolism

Prominence of prophylaxis to prevent Venous Thromboembolism

Object Description

Description

Prominence of prophylaxis to prevent Venous Thromboembolism

Prominence of prophylaxis to prevent Venous Thromboembolism